« Class Action For Penis Enlargement Products | Main | Side Effects »
May 27, 2005
FDA Rebuffs New Risperdal Use
It seems the FDA is taking a slow and cautious route on new approvals, especially after the Vioxx withdrawal, as we noted before. In April, the FDA ordered new warnings on all antipsychotic drugs, including Risperdal, to alert physicians to a higher death rate when the medicines are prescribed for the atypical use of treating dementia in elderly patients.
|
Related Products: |
Read more from this blogger: |
Posted on May 27, 2005 05:26 PM by Vioxx68.
Filed in Personal Injury Resources under vioxx.
Permalink
| Comments (0)
Share |
